Novavax (NASDAQ:NVAX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Novavax (NVAX) operate in?

Novavax is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Novavax Stock (NASDAQ: NVAX) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	27.64K / 7.01M
Day Range	- - -
52 Wk Range	3.53 - 23.86
Market Cap	$2.09B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	53
Short Interest	24.63%
Days to Cover	6.83

Recent News

DeSantis Administration Cautions Against Pfizer, Moderna mRNA Covid Vaccines for Vulnerable Individuals, Cites Concerns Related To Rare Heart Conditions

Florida advises against mRNA Covid vaccines for vulnerable residents, citing safety concerns. Gov. DeSantis' administration urges healthcare providers to prioritize alternative vaccines for seniors and high-risk individuals.

Vandana Singh

Why Are Novavax Shares Trading Lower Today?

Novavax Inc. (NASDAQ: NVAX) shares are trading lower Thursday following multiple significant announcements. Here's what you need to know.

Vaishali Prayag

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet

Here's a look at five stocks that saw increased attention from Benzinga readers during the week and the reasons why.

Chris Katje

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

May

Jun

Jul

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Novavax, Inc.

Sector

Health Care

Industry

Biotechnology

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical sta...

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Novavax (NVAX) stock?

You can purchase shares of Novavax (NASDAQ:NVAX) through any online brokerage.

View our list of the best stock brokerages

Who are Novavax (NVAX) competitors?

Other companies in Novavax’s space includes: Centessa Pharmaceuticals (NASDAQ:CNTA), SpringWorks Therapeutics (NASDAQ:SWTX), Arrowhead Pharma (NASDAQ:ARWR), Kiniksa Pharmaceuticals (NASDAQ:KNSA) and Bicycle Therapeutics (NASDAQ:BCYC).

What is the forecast, or price target, for Novavax (NVAX) stock?

Novavax has a consensus price target of $51.00.

What is the current price for Novavax (NVAX)?

The stock price for Novavax (NASDAQ: NVAX) is $13.05 last updated September 23, 2024 at 8:35 AM EDT.

Does Novavax (NVAX) pay a dividend?

There are no upcoming dividends for Novavax.

When is Novavax (NASDAQ:NVAX) reporting earnings?

Novavax’s Q3 earnings are confirmed for Thursday, November 7, 2024.

Is Novavax (NVAX) going to split?

There is no upcoming split for Novavax.

What sector and industry does Novavax (NVAX) operate in?

Novavax is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Get Our Top Trade Ideas Delivered Daily - 65% Off Now